USP Lithium Carbonate for Bipolar Medication API from Japan
Ultra-pure USP lithium carbonate serving as the active pharmaceutical ingredient (API) in medications for mood stabilization. This is a chemically defined lithium carbonate, classifiable under Chapter 28. It is not a finished drug and is not excluded by Chapter 28 notes.
Duty Rate — Japan → Canada
0%
Import Tips
• Provide API certification and USP compliance documentation
• Ensure the product is not formulated into tablets or capsules
• Verify Health Canada import requirements for pharmaceutical ingredients